Search research articles
Contact Us
Filters
Showing results (181-190 of 241) with videos related to
Page
of 25
Sort By:
Investigational New Drugs
|
October 4, 2011
Phase I dose-escalating study of panobinostat (LBH589) administered intravenously to Japanese patients with advanced solid tumors
Sachi Morita, Satoshi Oizumi, Hironobu Minami, et al.
Molecular and Clinical Oncology
|
March 17, 2023
Feasibility assessment of global standard chemoradiotherapy followed by surgery in patients with esophageal cancer
Yao Liang, Osamu Maeda, Kazushi Miyata, et al.
Cancer Chemotherapy and Pharmacology
|
February 2, 2013
A phase I study of tasisulam sodium using an albumin-tailored dose in Japanese patients with advanced solid tumors
Yutaka Fujiwara, Yuichi Ando, Toru Mukohara, et al.
Obesity Research & Clinical Practice
|
December 19, 2013
High prevalence of periodontitis in non-elderly obese Japanese adults
Sayaka Katagiri, Hiroshi Nitta, Toshiyuki Nagasawa, et al.
Cancers
|
November 14, 2023
Low Expectancy of Conversion Surgery with R0 Resection in Patients with CEA > 5.0 ng/mL at the Initial RECIST Evaluation for Metastatic Gastric Cancer
Koki Nakanishi, Chie Tanaka, Mitsuro Kanda, et al.
Cancer Science
|
August 2, 2016
Modified two-dimensional response as surrogate marker of overall survival in patients with metastatic colorectal cancer
Goro Nakayama, Tsutomu Fujii, Kenta Murotani, et al.
Cancer Medicine
|
May 21, 2026
Feasibility Study of Trifluridine/Tipiracil and Zolbetuximab as Third- or Later-Line Chemotherapy for CLDN18.2-Positive and HER2-Negative Gastric or Gastroesophageal Junction Adenocarcinoma: A Study Protocol
Osamu Maeda, Chie Tanaka, Kazuhiro Furukawa, et al.
Obesity Research & Clinical Practice
|
December 17, 2013
Reduced masticatory function in non-elderly obese Japanese adults
Sayaka Katagiri, Hiroshi Nitta, Toshiyuki Nagasawa, et al.
International Journal of Clinical Oncology
|
August 10, 2017
Feasibility of dose-dense epirubicin and cyclophosphamide with subcutaneous pegfilgrastim 3.6 mg support: a single-center prospective study in Japan
Sachi Morita, Toyone Kikumori, Nobuyuki Tsunoda, et al.
Journal of the National Cancer Institute
|
January 31, 2008
Re: UGT1A1*28 genotype and irinotecan-induced neutropenia: dose matters
Wataru Ichikawa, Kazuhiro Araki, Ken-ichi Fujita, et al.
Page
of 25
Search research articles
Search
Showing results (181-190 of 241) with videos related to
Sort By:
Page
of 25
Investigational New Drugs
|
October 4, 2011
Phase I dose-escalating study of panobinostat (LBH589) administered intravenously to Japanese patients with advanced solid tumors
Sachi Morita, Satoshi Oizumi, Hironobu Minami, et al.
Molecular and Clinical Oncology
|
March 17, 2023
Feasibility assessment of global standard chemoradiotherapy followed by surgery in patients with esophageal cancer
Yao Liang, Osamu Maeda, Kazushi Miyata, et al.
Cancer Chemotherapy and Pharmacology
|
February 2, 2013
A phase I study of tasisulam sodium using an albumin-tailored dose in Japanese patients with advanced solid tumors
Yutaka Fujiwara, Yuichi Ando, Toru Mukohara, et al.
Obesity Research & Clinical Practice
|
December 19, 2013
High prevalence of periodontitis in non-elderly obese Japanese adults
Sayaka Katagiri, Hiroshi Nitta, Toshiyuki Nagasawa, et al.
Cancers
|
November 14, 2023
Low Expectancy of Conversion Surgery with R0 Resection in Patients with CEA > 5.0 ng/mL at the Initial RECIST Evaluation for Metastatic Gastric Cancer
Koki Nakanishi, Chie Tanaka, Mitsuro Kanda, et al.
Cancer Science
|
August 2, 2016
Modified two-dimensional response as surrogate marker of overall survival in patients with metastatic colorectal cancer
Goro Nakayama, Tsutomu Fujii, Kenta Murotani, et al.
Cancer Medicine
|
May 21, 2026
Feasibility Study of Trifluridine/Tipiracil and Zolbetuximab as Third- or Later-Line Chemotherapy for CLDN18.2-Positive and HER2-Negative Gastric or Gastroesophageal Junction Adenocarcinoma: A Study Protocol
Osamu Maeda, Chie Tanaka, Kazuhiro Furukawa, et al.
Obesity Research & Clinical Practice
|
December 17, 2013
Reduced masticatory function in non-elderly obese Japanese adults
Sayaka Katagiri, Hiroshi Nitta, Toshiyuki Nagasawa, et al.
International Journal of Clinical Oncology
|
August 10, 2017
Feasibility of dose-dense epirubicin and cyclophosphamide with subcutaneous pegfilgrastim 3.6 mg support: a single-center prospective study in Japan
Sachi Morita, Toyone Kikumori, Nobuyuki Tsunoda, et al.
Journal of the National Cancer Institute
|
January 31, 2008
Re: UGT1A1*28 genotype and irinotecan-induced neutropenia: dose matters
Wataru Ichikawa, Kazuhiro Araki, Ken-ichi Fujita, et al.
Page
of 25